Everest Medicines Ltd (HKSE:01952)
HK$ 34.3 -0.1 (-0.29%) Market Cap: 11.05 Bil Enterprise Value: 9.56 Bil PE Ratio: 0 PB Ratio: 2.33 GF Score: 41/100

Full Year 2021 Everest Medicines Ltd Earnings Call Transcript

Mar 29, 2022 / 01:00AM GMT
Release Date Price: HK$21.6 (+2.61%)
Operator

Good day, and thank you for standing by. Welcome to the Everest Medicines Full Year 2021 Earnings Conference Call. Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Leah Liu, VP of Corporate Affairs.

Leah Liu

Thank you, operator, and good morning, everyone. Thank you all for joining this call. For this call this morning, we would like to discuss our 2021 full year results and give you an update on our business. The details of the full year results is available on our website. Joining me today from the company are Dr. Kerry Blanchard, our CEO; Ian Woo, our President and CFO; and Neo Zhang, our COO.

Before we get started, I'd like to remind you that the speakers of this conference call may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the company or its officers with respect to the business operations and financial conditions of the company, which can be identified by terminology

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot